CervoMed Inc.
CRVO | NASDAQ
$2.43
+$0.02 (+0.83%)
Sep 22, 2026, 11:00 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Net Income | -26.97M | -16.29M | -2.17M | -5.8M | -24.1M | -14.19M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | 93.42K | 103.17K |
Stock-Based Compensation | 1.45M | 1.41M | 407.63K | 333.84K | 897.26K | 736.12K |
Other Working Capital | 1.16M | 49.2K | 88.88K | 300.78K | -249K | 518.17K |
Other Non-Cash Items | -854.08K | -1.21M | -5.42M | 2.52M | 8.69M | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | -443.89K | -1.68M |
Change in Working Capital | 2.92M | -440.66K | -261.36K | 379.94K | 356.37K | 1.47M |
Operating Cash Flow | -23.45M | -16.53M | -7.45M | -2.57M | -14.5M | -13.55M |
Capital Expenditures | n/a | n/a | n/a | -1 | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | 4K | n/a |
Purchase of Investments | -25.4M | -48.1M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 43.5M | 19.44M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 18.1M | -28.66M | n/a | n/a | 4K | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | 6M | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 10.34M | n/a | -3.8M | 7.06M |
Financial Cash Flow | 4.59M | 46.4M | 11.15M | n/a | 33.3M | 17.89M |
Net Cash Flow | -764.03K | 1.21M | 3.7M | -33.22M | 18.8M | 4.34M |
Free Cash Flow | -23.45M | -16.53M | -7.45M | -2.57M | -14.5M | -13.55M |
Adj. Free Cash Flow | -24.9M | -17.94M | -7.86M | -2.91M | -15.4M | -14.29M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | -1 | n/a | n/a |
Owner Earnings | -23.45M | -16.53M | -7.45M | -2.57M | -14.5M | -13.55M |
Add to Watchlist
Select watchlists to add or remove CRVO